Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor

Case Reports in Hematology
Elizabeth S JohnJulio Hajdenberg

Abstract

Factor V deficiency secondary to inhibitors is extremely rare and can be caused by a wide collection of exposures such as bovine thrombin and beta lactamase antibiotics. The management of factor V deficiency with inhibitor is a condition treated based on case reports due to the rarity of this condition. We describe a complicated case of an elderly patient with severe factor V deficiency with high inhibitor titer refractory to FEIBA (anti-inhibitor coagulation complex) treated with NovoSeven concurrently with cyclosporine immunosuppression and Rituxan. Given that there are no consensus guidelines on treatment, this case offers important insight into the therapeutic approaches that can be used to treat such patients.

References

May 1, 2009·Thrombosis and Haemostasis·Ai Leen AngHeng Joo Ng
Nov 6, 2010·Journal of Thrombosis and Thrombolysis·Massimo Franchini, Giuseppe Lippi

❮ Previous
Next ❯

Citations

Nov 30, 2019·Haemophilia : the Official Journal of the World Federation of Hemophilia·Oluwaseun OlaiyaShannon L Carpenter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Zeitschrift für Laryngologie, Rhinologie, Otologie und ihre Grenzgebiete
A HAGER, F HOLZKNECHT
L'unión médicale du Canada
V LATRAVERSE
Vestnik otorinolaringologii
S I KATSENELENBOGEN
The Journal of the American Osteopathic Association
H I STEIN, A D DUBIN
© 2021 Meta ULC. All rights reserved